Third, we identified the binding site of AP‐1 and its regulatory region on the NR4A1 promoter, further elucidating how disturbed flow amplifies AP‐1‐driven transcriptional activation of NR4A1 and highlighting a previously unexplored relationship between inflammation and metabolic dysfunction in the context of atherosclerosis. The gene discussed is NR4A1; the disease is atherosclerosis.